Gut Health
GABRIELLA NAGY
3 MIN LESEN

What Is SIBO? Our Guide To Small Intestine Bacterial Overgrowth

What Is SIBO? Our Guide To Small Intestine Bacterial Overgrowth

SIBO is a condition in which bacteria normally found in the colon proliferates in large numbers in the small intestine.1 Signs and symptoms may vary due to the type of bacterial overgrowth2 and the severity of disease.3 Typical symptoms tend to overlap with those of IBS, and include bloating, abdominal pain, flatulence, diarrhoea and/or constipation, weight loss, malabsorption, malnutrition and osteoporosis.1,2 Several conditions are also linked with SIBO such as rosacea, hypothyroid, lactose intolerance, coeliac disease, inflammatory bowel disease, chronic fatigue syndrome and fibromyalgia to name a few.

How to fix it 

The 5R gut restoration protocol, implemented in the correct sequence, can be effective in managing SIBO:

Remove

Simple sugars and well-absorbed carbohydrates (such as grains, legumes, starchy vegetables) should be eliminated, as they feed the bacteria creating symptoms and fuel more bacterial growth. Reduction of any drugs that reduce intestinal motility or stomach acidity to its lowest possible level is also advised1. Conventionally, antibiotics are used to eradicate SIBO4 but due to potential adverse effects,8 specific strain probiotics (such as Lactobacillus casei and L. acidophilus) can be used as an alternative therapy.8,9

Replace

Insufficient stomach acid, bile and digestive enzymes may be a key factor in SIBO,4 and replacing these through supplementation may be required to decrease ingested bacterial load. Any nutritional deficiencies as a consequence of SIBO (particularly vitamins A, D, E, K and B12, calcium and magnesium)2 will need to be corrected.

Re-inoculate 

As a second stage process, once SIBO has been removed, multi-strain probiotics are used to re- establish a healthy gut microflora balance.10

Repair

SIBO can cause inflammation and damage the lining of the small intestine.2 As part of the second stage, gut healing nutrients such as L-glutamine,11 essential fatty acids, zinc and quercetin;12,13 and anti-inflammatory agents such as curcumin and resveratrol14 can be used to repair the gut.

Rebalance

Stress has a negative effect on gut motility, intestinal permeability, gut barrier regeneration, gut flora balance and the immune system.15 Stress management is therefore important in maintaining gut health. In addition, spacing meals 4-5 hours apart will allow the small intestine to clear away bacteria at night and in between meals.16

What causes it? 

There are several natural defenses that prevent bacterial overgrowth in the small intestine. Stomach acid, bile and pancreatic juices destroy or limit bacterial growth. Muscular activity of the small intestine work to propel not only food, but also bacteria away and out into the colon. The intestinal mucus layer and the immune system also aid in preventing bacterial proliferation. SIBO can develop if some of these defence mechanisms are disrupted.4

Who's at risk?

Though the following factors do not necessarily lead to SIBO, there is evidence that they lead to an increased risk of developing it:

  • Chronic antacid use7
  • Recurrent antibiotic use2
  • Use of narcotics1
  • The elderly2
  • Gastrointestinal surgery1
  • Those with constipation, IBS, diabetes, coeliac disease, low stomach acid, scleroderma, intestinal diverticulosis, and intestinal obstructions caused by strictures, adhesions and cancer.1,2

Diagnosing SIBO

The most efficient and non-invasive method for testing for SIBO is through a glucose and hydrogen breath test.6

Take the gut health quiz!

Get articles, product recommendations & information based on your symptoms.

Start now

Verweise

  1. Sachdev, AH und Pimentel, M., 2013. Gastrointestinale bakterielle Überwucherung: Pathogenese und klinische Bedeutung. Therapeutische Fortschritte bei chronischen Erkrankungen, 4(5), S. 223-231.
  2. Dukowicz, AC, Lacy, BE und Levine, GM, 2007. Bakterielle Überwucherung des Dünndarms: eine umfassende Übersicht. Gastroenterology & hepatology, 3(2), S. 112.
  3. Grace, E., Shaw, C., Whelan, K. und Andreyev, HJN, 2013. Bakterielle Überwucherung des Dünndarms – Prävalenz, klinische Merkmale, aktuelle und sich entwickelnde diagnostische Tests und Behandlung. Alimentary pharmacology & therapeutics, 38(7), S. 674–688.
  4. Bures, J., Cyrany, J., Kohoutova, D., Förstl, M., Rejchrt, S., Kvetina, J., Vorisek, V. und Kopacova, M., 2010. Syndrom der bakteriellen Überwucherung des Dünndarms. Weltzeitschrift für Gastroenterologie: WJG, 16(24), S. 2978.
  5. Franco, DL, Disbrow, MB, Kahn, A., Koepke, LM, Harris, LA, Harrison, ME, Crowell, MD und Ramirez, FC, 2015. Duodenalaspiration bei bakterieller Überwucherung des Dünndarms: Ausbeute, PPIs und Ergebnisse nach der Behandlung in einem tertiären akademischen medizinischen Zentrum. Gastroenterologische Forschung und Praxis, 2015.
  6. Ghoshal UC (2011). So interpretieren Sie Wasserstoff-Atemtests. Journal of neurogastroenterology and motility, 17(3), 312– 317. doi:10.5056/jnm.2011.17.3.312
  7. Lo, WK und Chan, WW, 2013. Verwendung von Protonenpumpenhemmern und das Risiko einer bakteriellen Überwucherung des Dünndarms: eine Metaanalyse. Clinical Gastroenterology and Hepatology, 11(5), S. 483–490.
  8. Chen, WC, & Quigley, EM (2014). Probiotika, Präbiotika und Synbiotika bei bakterieller Überwucherung im Dünndarm: Neue therapeutische Möglichkeiten! The Indian Journal of Medical Research, 140(5), 582–584.
  9. Soifer, LO, Peralta, D., Dima, G. und Besasso, H., 2010. Vergleichende klinische Wirksamkeit eines Probiotikums gegenüber einem Antibiotikum bei der Behandlung von Patienten mit bakterieller Überwucherung des Darms und chronischer funktioneller Blähungen: eine Pilotstudie. Acta gastroenterologica Latinoamericana, 40(4), S. 323–327.
  10. L Madsen, K., 2012. Verbesserung der epithelialen Barrierefunktion durch Probiotika. Journal of Epithelial Biology and Pharmacology, 5(1).
  11. Krishna Rao, R. (2012). Rolle von Glutamin beim Schutz von engen Verbindungen des Darmepithels. Journal of Epithelial Biology and Pharmacology, 5(1), S. 47–54.
  12. Dulantha Ulluwishewa, Rachel C. Anderson, Warren C. McNabb, Paul J. Moughan, Jerry M. Wells, Nicole C. Roy., 2011. Regulierung der Tight Junction-Durchlässigkeit durch Darmbakterien und Nahrungsbestandteile, The Journal of Nutrition, Band 141, Ausgabe 5, Seiten 769–776, https://doi.org/10.3945/jn.110.135657
  13. Lan, A., Blachier, F., Benamouzig, R., Beaumont, M., Barrat, C., Coelho, D., Lancha Jr, A., Kong, X., Yin, Y., Marie, JC und Tomé, D., 2014. Schleimhautheilung bei entzündlichen Darmerkrankungen: Ist eine Nahrungsergänzung sinnvoll?. Entzündliche Darmerkrankungen, 21(1), S. 198-207.
  14. Bereswill, S., Muñoz, M., Fischer, A., Plickert, R., Haag, LM, Otto, B., Kühl, AA, Loddenkemper, C., Göbel, UB und Heimesaat, MM, 2010. Entzündungshemmende Wirkung von Resveratrol, Curcumin und Simvastatin bei akuter Dünndarmentzündung. PloS one, 5(12), p.e15099.
  15. Konturek, PC, Brzozowski, T. und Konturek, SJ, 2011. Stress und der Darm: Pathophysiologie, klinische Folgen, diagnostischer Ansatz und Behandlungsmöglichkeiten. J Physiol Pharmacol, 62(6), S. 591-599.
  16. Pimentel, M., 2006. Eine neue IBS-Lösung. Kalifornien, Health Point Press.